Red Cat Holdings is a Utah-based maker of small and tactical uncrewed aircraft systems (UAS) for defense and national security customers. Across seven identifiable, non-stale analyst targets, the individual price objectives are $6 (Piper Sandler, Clarke Jeffries, October 23, 2026), $19 (Clear Street, Brian Dobson, October 19), $15 (Evercore ISI, Amit Daryanani, October 14), $13 (Northland Securities, Michael Latimore, September 17), $25 (Roth MKM, Craig Irwin, August 11), $15 (Needham, Austin Bohlig, August 7), and $20 (H.C. Wainwright, Amit Dayal, August 7). Their arithmetic mean is about $16.14, rounded to a $16 central target.
The dispersion is unusually wide — from $6 to $25 — signaling a genuine split between cautious analysts focused on near-term execution and bullish analysts focused on multi-year defense demand. The average analyst price target clusters around $15.60 to $16.30 depending on the source and look-back window, consistent with the $16 figure used here. Recent action has been downward: Piper Sandler cut its target from $9 to $6 in October while maintaining a Neutral rating, while several Buy-rated firms have kept targets between $13 and $25. This is not a tight consensus, and the mean should be read as a reference point, not a forecast.
The shares closed at about $3.53 on November 16, 2026, down roughly 7% in the session, and slid further in after-hours trading following a third-quarter earnings miss. The stock sits just above its 52-week range low of about $3.25, far below its 52-week high near $18.78. Reaching $16 therefore implies a gain of roughly 350%, a very large move that would require a fundamental re-rating, not a routine rally.
The path would need to run through restored revenue visibility. In the quarter ended September 30, 2026, revenue of about $11.8 million missed a consensus estimate near $42 million, and the company withdrew its full-year 2026 revenue guidance. The stock price target of $16 implicitly assumes a return to growth, margin recovery, and renewed confidence in contract awards — conditions that are not currently priced in.
RCAT has been in a sustained downtrend, down more than 50% over the trailing 12 months and roughly 63% over three months. The 52-week low near $3.25 is the key support level, and after-hours trading following the earnings report briefly pushed the shares below it. On the upside, resistance is likely to emerge around the $6 level — the lowest current analyst target and a prior support-turned-resistance zone — followed by the $9–$10 area and the cluster of targets near $15. A durable move toward $16 would require reclaiming and holding well above these levels, which have not been tested recently.
Analyst price targets generally reflect a roughly 12-month research horizon, though the targets used here were issued between August and October 2026 and carry differing assumptions. Investors should watch whether the company restores or revises its revenue outlook, the pace of Army and international deliveries, gross margin trends, any closing terms for the Steyr Motors acquisition, further analyst target revisions, and capital-raising activity given the recent share count growth. Macro drivers such as U.S. defense budget execution and interest-rate expectations also matter for a pre-profit, high-beta growth stock.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile name like RCAT, these tools can help traders spot shifting trends, monitor positions, and surface opportunities more efficiently than manual review. Traders can use the signals to stay ahead of momentum changes and manage risk across their watchlists.
The $16 central target is an average of seven current analyst price targets spanning $6 to $25, and it sits roughly 350% above the latest closing price near $3.53 — an enormous required move. Support comes from a genuine Army program, early international sales, and a healthy cash balance, while the bearish case rests on withdrawn guidance, a missed competition, negative margins, and dilution. The wide analyst range shows there is no clean consensus, and the near-term trend and technical structure remain firmly against the stock. Whether RCAT approaches $16 depends on a credible return to revenue growth and profitability; the next earnings print, guidance updates, and analyst revisions will be the most important signposts. No outcome is guaranteed, and this is not a recommendation to buy or sell.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, RCAT has been loosely correlated with DPRO. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RCAT jumps, then DPRO could also see price increases.
| Ticker / NAME | Correlation To RCAT | 1D Price Change % | ||
|---|---|---|---|---|
| RCAT | 100% | -13.78% | ||
| DPRO - RCAT | 65% Loosely correlated | -17.01% | ||
| KTOS - RCAT | 65% Loosely correlated | -1.95% | ||
| LUNR - RCAT | 64% Loosely correlated | -3.36% | ||
| KOPN - RCAT | 59% Loosely correlated | -4.70% | ||
| SPAI - RCAT | 58% Loosely correlated | -13.40% | ||
More | ||||
| Ticker / NAME | Correlation To RCAT | 1D Price Change % |
|---|---|---|
| RCAT | 100% | -13.78% |
| RCAT (3 stocks) | 77% Closely correlated | -7.76% |
| Aerospace & Defense (87 stocks) | 36% Loosely correlated | -6.65% |